LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept.
已完结10由 钱钱 发布于 2025/4/22 9:42:54
DOI:10.1016/j.cmet.2022.07.013
作者:Tamer Coskun, Shweta Urva, William C Roell, Hongchang Qu, Corina Loghin, Julie S Moyers, Libbey S O'Farrell, Daniel A Briere, Kyle W Sloop, Melissa K Thoma
文献类型:期刊论文
补充材料:只需要正文